FDA Drug Application (078183) for CIPROFLOXACIN EXTENDED RELEASE by MYLAN PHARMS INC

Back to FDA Applications sponsored by MYLAN PHARMS INC

Application Number078183
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage212.6MG;EQ 287.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCIPROFLOXACIN EXTENDED RELEASE
Active IngredientCIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE



Back to FDA Applications sponsored by MYLAN PHARMS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.